Learn more

INST BIOTECHNOLOGII I ANTYBIOTYKÓW

Overview
  • Total Patents
    12
  • GoodIP Patent Rank
    212,462
  • Filing trend
    ⇩ 100.0%
About

INST BIOTECHNOLOGII I ANTYBIOTYKÓW has a total of 12 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2006. It filed its patents most often in Poland, WIPO (World Intellectual Property Organization) and United States. Its main competitors in its focus markets biotechnology and pharmaceuticals are FEDERALNOE GOSUDARSTVENNOE UNITARNOE PREDPRIYATIE GOSUDARSTVENNYJ NAUCHNO ISSLEDOVATELSKIJ INST OSOB, AKSHAYA BIO INC and BIOLOGICAL MIMETICS INC.

Patent filings in countries

World map showing INST BIOTECHNOLOGII I ANTYBIOTYKÓWs patent filings in countries

Patent filings per year

Chart showing INST BIOTECHNOLOGII I ANTYBIOTYKÓWs patent filings per year from 1900 to 2020

Focus industries

Top inventors

# Name Total Patents
#1 Płucienniczak Andrzej 8
#2 Płucienniczak Grażyna 7
#3 Borowicz Piotr 7
#4 Sokołowska Iwona 6
#5 Stadnik Dorota 5
#6 Antosik Jarosław 5
#7 Łukasiewicz Natalia 5
#8 Zieliński Marcin 5
#9 Kęsik-Brodacka Małgorzata 5
#10 Oszczapowicz Irena 4

Latest patents

Publication Filing date Title
PL415888A1 Method for producing insulin and its derivatives and the hybrid peptide used in this method
PL399287A1 Insulin analog or a pharmaceutically tolerated salt thereof, a pharmaceutical composition of prolonged therapeutic use of insulin analog, dosage and method for treatment of diabetes
PL397663A1 The new melphalan derivatives, processes for their preparation, pharmaceutical composition containing them and the medical use
PL395937A1 Expression cassette, the use of the expression cassette, the expression vector, prokaryotic host cell comprising an expression vector, the bacterial strain and the method for producing a polypeptide
PL393508A1 Recombinant monoclonal antibody with high affinity to the bacterial antigen of native and functional structure, process for the preparation of monoclonal antibodies and the use of recombinant monoclonal antibodies
PL216871B1 New derivatives of anthracyclinic antybiotics and method to obtain them
PL385586A1 New slow-release insulin analogues
PL380812A1 Composition in form of gel used in cosmetics and/or dermatology